These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 17118982

  • 1. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
    Nawar HF, Arce S, Russell MW, Connell TD.
    Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
    [Abstract] [Full Text] [Related]

  • 2. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
    Nawar HF, Arce S, Russell MW, Connell TD.
    Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW.
    Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
    [Abstract] [Full Text] [Related]

  • 4. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli.
    Lee CH, Hajishengallis G, Connell TD.
    J Microbiol Biotechnol; 2017 Apr 28; 27(4):709-717. PubMed ID: 28144014
    [Abstract] [Full Text] [Related]

  • 5. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.
    Zhao W, Zhao Z, Russell MW.
    Mol Oral Microbiol; 2011 Jun 28; 26(3):200-9. PubMed ID: 21545697
    [Abstract] [Full Text] [Related]

  • 6. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
    Connell TD.
    Expert Rev Vaccines; 2007 Oct 28; 6(5):821-34. PubMed ID: 17931161
    [Abstract] [Full Text] [Related]

  • 7. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
    Lee CH, Masso-Welch P, Hajishengallis G, Connell TD.
    J Leukoc Biol; 2011 Nov 28; 90(5):911-21. PubMed ID: 21791597
    [Abstract] [Full Text] [Related]

  • 8. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.
    Arce S, Nawar HF, Russell MW, Connell TD.
    Infect Immun; 2005 May 28; 73(5):2718-27. PubMed ID: 15845474
    [Abstract] [Full Text] [Related]

  • 9. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
    Nawar HF, Greene CJ, Lee CH, Mandell LM, Hajishengallis G, Connell TD.
    Vaccine; 2011 Jan 17; 29(4):721-7. PubMed ID: 21095251
    [Abstract] [Full Text] [Related]

  • 10. Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.
    Lee CH, Nawar HF, Mandell L, Liang S, Hajishengallis G, Connell TD.
    Vaccine; 2010 May 07; 28(21):3696-705. PubMed ID: 20332049
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
    Norton EB, Lawson LB, Freytag LC, Clements JD.
    Clin Vaccine Immunol; 2011 Apr 07; 18(4):546-51. PubMed ID: 21288994
    [Abstract] [Full Text] [Related]

  • 12. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
    Mathias-Santos C, Rodrigues JF, Sbrogio-Almeida ME, Connell TD, Ferreira LC.
    Clin Vaccine Immunol; 2011 Aug 07; 18(8):1243-51. PubMed ID: 21677110
    [Abstract] [Full Text] [Related]

  • 13. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC, Clements JD.
    Infect Immun; 2001 Mar 07; 69(3):1528-35. PubMed ID: 11179323
    [Abstract] [Full Text] [Related]

  • 14. Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).
    Nawar HF, Berenson CS, Hajishengallis G, Takematsu H, Mandell L, Clare RL, Connell TD.
    Clin Vaccine Immunol; 2010 Jun 07; 17(6):969-78. PubMed ID: 20392887
    [Abstract] [Full Text] [Related]

  • 15. Immunostimulatory activity of LT-IIa, a type II heat-labile enterotoxin of Escherichia coli.
    Connell TD, Metzger D, Sfintescu C, Evans RT.
    Immunol Lett; 1998 Jun 07; 62(2):117-20. PubMed ID: 9698108
    [Abstract] [Full Text] [Related]

  • 16. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET, Crean TI, John M, Butterton JR, Clements JD, Calderwood SB.
    Infect Immun; 1999 Apr 07; 67(4):1694-701. PubMed ID: 10085006
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens.
    Miller T, Fanton M, Nickelson S, Mason H, Webb S.
    Avian Pathol; 2012 Oct 07; 41(5):441-9. PubMed ID: 22928883
    [Abstract] [Full Text] [Related]

  • 18. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
    de Haan L, Verweij WR, Feil IK, Holtrop M, Hol WG, Agsteribbe E, Wilschut J.
    Immunology; 1998 Jul 07; 94(3):424-30. PubMed ID: 9767427
    [Abstract] [Full Text] [Related]

  • 19. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR, de Haan L, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J.
    Vaccine; 1998 Dec 07; 16(20):2069-76. PubMed ID: 9796066
    [Abstract] [Full Text] [Related]

  • 20. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.
    Vance DJ, Greene CJ, Rong Y, Mandell LM, Connell TD, Mantis NJ.
    Clin Vaccine Immunol; 2015 Dec 07; 22(12):1285-93. PubMed ID: 26491037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.